Home
Investors & Media
Press Releases
Press Releases
06/22/2022
Tobias Leipold, CEO and Co-Founder, leaves eHealth-Tec GmbH
05/31/2022
Betül Susamis Unaran leaves Zur Rose Group
04/28/2022
Zur Rose Group AG: Shareholders approve all proposals
04/20/2022
Zur Rose Group sees revenue perform as expected in the first quarter of 2022
04/06/2022
Zur Rose Group AG publishes invitation to the Annual General Meeting of 28 April 2022
Ad hoc announcement pursuant to Art. 53 LR
03/28/2022
Max Müller to be new CEO of TeleClinic, taking over from founder and former CEO Katharina Jünger
03/24/2022
Zur Rose Group: Excellent starting position for e-prescriptions set up and ecosystem strategy successfully continued
Ad hoc announcement pursuant to Art. 53 LR
01/20/2022
Zur Rose Group: steady growth in a volatile market environment
01/10/2022
Zur Rose Group nominates Rongrong Hu as director
12/16/2021
Zur Rose and the Swiss Association for the Blind and Visually Impaired make it easier for people with a visual impairment to take medication
12/09/2021
Zur Rose Group successfully completed capital increase from authorised capital and sets placement price at CHF 290 per new share
Ad hoc announcement pursuant to Art. 53 LR
12/08/2021
Zur Rose Group decides on capital increase from authorised capital and starts accelerated bookbuilding to make full use of increasing market opportunities
Ad hoc announcement pursuant to Art. 53 LR
11/26/2021
eHealth-Tec achieves first place in the TOP 100 competition
10/28/2021
Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes
10/21/2021
Zur Rose Group: Board of Directors nominates Walter Oberhänsli as Chairman and appoints Walter Hess as new CEO
Ad hoc announcement pursuant to Art. 53 LR
10/21/2021
Zur Rose Group continues to grow strongly
Ad hoc announcement pursuant to Art. 53 LR
08/24/2021
Health app Well heralds the future of healthcare
08/18/2021
Zur Rose Group accelerates growth in second quarter with revenue up 26 per cent
Ad hoc announcement pursuant to Art. 53 LR
07/09/2021
No more paper: e-prescriptions are coming
06/15/2021
Zur Rose Group strengthens Group Management: Madhu Nutakki to become Chief Technology Officer
05/28/2021
Faster and more secure access to the gematik e-prescription with eHealth-Tec: Compatible software development kit for software providers
04/29/2021
Annual General Meeting of Zur Rose Group AG: Shareholders approve all proposals
04/29/2021
DocMorris expands management team: Dr. Ulrich Thomé is appointed Chief Strategy Officer
04/20/2021
Zur Rose Group signals dynamic revenue development in the first quarter of 2021
04/07/2021
Zur Rose Group AG publishes invitation to the Annual General Meeting on 29 April 2021
03/31/2021
Introducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering people with obesity to find relevant care for a better quality of life.
03/18/2021
Zur Rose Group further extends European market leadership and successfully implements healthcare platform
02/11/2021
DocMorris goes European: new branding for marketplaces in Spain and France
01/21/2021
The Zur Rose Group accelerates growth
01/13/2021
Zur Rose vindicated after court finds CEO Walter Oberhänsli not guilty
01/11/2021
Collaboration between Zur Rose Group and Novo Nordisk: The Zur Rose Group and Novo Nordisk combine their expertise to improve the health journeys of people with obesity
01/08/2021
TeleClinic builds on market leadership in telemedicine
12/18/2020
The healthcare platform of the future: DocMorris+ is launched
12/14/2020
Local Pharmacy Strengthening Act circumvents ECJ ruling
12/10/2020
Zur Rose Group AG: Olaf Heinrich, Head Germany, is leaving the Zur Rose Group; his successor will be Walter Hess, Head Switzerland
11/26/2020
New branding for a new vision: DocMorris
11/16/2020
Zur Rose Group: gematik awards tender for specialist e-prescription service - Zur Rose subsidiary eHealth-Tec involved as partner to IBM
11/13/2020
Allianz Care, CSS, Visana and Zur Rose Group in ground-breaking digital healthcare platform partnership
10/21/2020
Zur Rose Group accelerates growth in third quarter 2020
09/08/2020
Zur Rose and KPT together launch digital medicines assistant Medi+
08/19/2020
Zur Rose Group reinforces European market leadership by rigorously implementing the growth and platform strategy
08/17/2020
Zur Rose Group successfully concluded acquisition of the e-commerce and diabetes activities of Apotal Group
07/31/2020
Zur Rose Group successfully concluded acquisition of TeleClinic
07/17/2020
Zur Rose Group successfully completed capital increase from authorized capital and sets placement price
07/16/2020
Zur Rose Group AG resolves on capital increase from authorized Capital
07/16/2020
Zur Rose Group gives indications for half-year results
07/16/2020
Zur Rose Group acquires TeleClinic, Germany's leading telemedicine provider
06/26/2020
Zur Rose Group strengthens European market leadership through acquisition of mail-order and diabetes activities of Apotal Group
05/03/2020
Zur Rose Group: Charges in connection with mail-order of non-prescription drugs and electronic prescribing
04/23/2020
2020 Annual General Meeting of Zur Rose Group AG: Shareholders adopt all proposals
04/20/2020
Zur Rose Group AG publishes adjusted proposal for the creation of authorized share capital and withdraws the agenda item relating to the creation of additional conditional capital for the Annual General Meeting 2020
04/16/2020
Zur Rose Group starts 2020 with strong growth
04/02/2020
Zur Rose Group AG publishes invitation to the Annual General Meeting on 23 April 2020
03/26/2020
Zur Rose Group AG successfully completes the placement of CHF 175 million Convertible Bonds due 2025
03/26/2020
Zur Rose Group AG launches CHF 150 million Convertible Bonds due 2025 with up to CHF 25 million increase option
03/23/2020
COVID-19: Zur Rose is calling for an exception allowing the mail-orders for over-the-counter emergency, cold and flu medicines
03/19/2020
Zur Rose Group maintains growth momentum
03/12/2020
Zur Rose Group broadens its leadership structure and completes Group Management
01/22/2020
Zur Rose Group posts 30 per cent growth in 2019
01/13/2020
Zur Rose Group strengthens Group Management: Bernd Gschaider becomes Chief Operations Officer
12/27/2019
Zur Rose Group: Purchase price payment for medpex acquisition completed early by earn-out settlement
12/20/2019
Cooperation between Medbase and Zur Rose: The two joint ventures between Zur Rose and Medbase will commence operations at the start of the year
11/01/2019
Zur Rose Group AG increases public bond to CHF 200 million
10/29/2019
Cooperation between Migros and Zur Rose: Zur Rose and Migros open the first shop-in-shop pharmacy in French-speaking Switzerland
10/24/2019
Zur Rose Group AG successfully issues a public straight bond of CHF 180 million
10/23/2019
Zur Rose Group posts acceleration of growth in third quarter 2019
08/21/2019
Zur Rose Group grows almost 30 per cent in the first half of 2019
06/05/2019
Cooperation between Migros Group and Zur Rose: Zur Rose and Migros step up cooperation
05/23/2019
Zur Rose shareholders adopt all proposals
04/30/2019
Zur Rose Group AG publishes invitation to the Annual General Meeting of Shareholders on 23 May 2019
04/17/2019
Zur Rose Group grows 28 per cent in the first quarter of 2019
04/15/2019
The Zur Rose Group nominates three new board members
03/21/2019
The Zur Rose Group accelerates growth
03/12/2019
Zur Rose Group accelerates internationalisation
03/04/2019
Change on the Board of Directors of the Zur Rose Group
01/23/2019
Zur Rose Group realised its expansion goals in 2018 and grew by over 20 percent
01/07/2019
Zur Rose Group: Acquisition of medpex successfully concluded
01/03/2019
Zur Rose Group increases share capital
12/16/2021
Zur Rose and the Swiss Association for the Blind and Visually Impaired make it easier for people with a visual impairment to take medication
Archive
2018
2017
2016
2015
2014
2013
2012
2011
2010
Our Company
Main Markets & Brands
Organisation
Board of Directors
Executive Board
History
Investors & Media
Press Releases
All
Ad hoc News
Corporate News
Share Information
Taxable Value
Form 8937
Bond Information
Publications
Analyst Coverage
General Meeting of Shareholders
Corporate Governance
Financial Calendar
Photos
Subscribe to Press Releases
Contact Us
Careers
Search
DE
\
EN
\
FR
Our Company
Main Markets & Brands
Organisation
Board of Directors
Executive Board
History
Investors & Media
Press Releases
All
Ad hoc News
Corporate News
Share Information
Taxable Value
Form 8937
Bond Information
Publications
Analyst Coverage
General Meeting of Shareholders
Corporate Governance
Financial Calendar
Photos
Subscribe to Press Releases
Contact Us
Careers
Search
DE
\
EN
\
FR